Shilanski & Associates’s CRH CRH Stock Holding History

Shilanski & Associates’s Portfolio CRH Stock Details CRH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,814	Closed	-$213K	–	104
2023 Q2	$213K	Buy	+3,814	New	+$190K	0.09%	99
2022 Q1	–	Sell	-4,210	Closed	-$222K	–	129
2021 Q4	$222K	Buy	+4,210	New	+$208K	0.09%	101

Other funds holding CRH

CCI

Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Shilanski & Associates's CRH Position: Q3 2023 in Review

Shilanski & Associates sold out of CRH (CRH) in Q3 2023, closing a stake of 3,814 shares — an estimated $213K sold.

Shilanski & Associates first reported a position in CRH in Q4 2021 and held it in 2 quarters. The position peaked at $222K in Q4 2021. 431 funds tracked by Wall St. Rank hold CRH as of Q3 2023.

Shilanski & Associates reported no remaining CRH position as of Q3 2023 after selling out during the quarter.
Shilanski & Associates sold 3,814 CRH shares in Q3 2023, an estimated $213K.
Shilanski & Associates first reported a position in CRH in Q4 2021 and held it in 2 quarters.
Shilanski & Associates's CRH position peaked at $222K in Q4 2021.
431 funds tracked by Wall St. Rank held CRH as of Q3 2023.

Based on Shilanski & Associates's 13F filing for Q3 2023, filed 14 Nov 2023.